NASDAQ:NTEC - Intec Pharma Ltd.
$6.39
 $0.13
+2.08%
4:00PM EDT
2019-04-18
Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs. The Company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinsons disease patients. Its pipeline also comprises The Accordion Pill-Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Furthermore under research is Accordion Pill-Undisclosed Drug for the prevention and treatment of small bowel non-steroidal anti-inflammatory drug (NSAID) induced ulcers. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  NTEC     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 07   203. 85   241. 91  
42 stocks rank:  4. 32 K 1. 44 K 1. 05 K
# analyst opinions:  5. 00   14. 51   13. 97  

quick ratio:  5. 57   5. 27   1. 81  
current ratio:  5. 69   5. 62   2. 25  

target price low:  10. 00   84. 80   115. 21  
target price avg:  14. 00   111. 51   137. 51  
target price high:  17. 00   135. 81   157. 84  
1-yr high:  9. 12   114. 23   138. 78  
last close:  6. 39   87. 66   116. 69  
50-day avg:  7. 48   95. 54   123. 44  
200-day avg:  6. 10   94. 25   121. 11  
1-yr low:  3. 65   72. 78   98. 34  
volume:  123. 86 K 4. 11 M 8. 07 M
50-day avg volume:  290. 41 K 2. 76 M 5. 02 M
200-day avg volume:  209. 10 K 2. 92 M 4. 59 M

1-day return:  2. 08 % -0. 41 % 0. 07 %
this week return:  0. 16 % -5. 74 % -4. 11 %
12-wk return:  -18. 08 % 1. 61 % -0. 05 %
52-wk return:  21. 55 % 3. 12 % 8. 78 %

enterprise value (EV):  171. 78 M 48. 94 B 114. 64 B
market cap:  212. 36 M 43. 07 B 104. 73 B
EBITDA:  -42. 47 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -4. 04   4. 22   12. 73  
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -43. 54 M 2. 20 B 4. 20 B

shares outstanding:  33. 23 M 571. 70 M 1. 24 B
shares:  23. 69 M 571. 81 M 1. 23 B
shares short:  730. 26 K 10. 17 M 13. 00 M
shares short prior month:  563. 52 K 9. 54 M 17. 33 M
short ratio:  2. 71   5. 41   3. 28  
short % of float:  2. 62 % 5. 45 % 2. 38 %
total cash/share:  1. 22   11. 14   9. 33  
total cash:  40. 58 M 6. 71 B 7. 15 B
free cash flow:  -27. 61 M 3. 58 B 2. 96 B
operating cash flow:  -39. 08 M 4. 15 B 4. 30 B

book value:  1. 61   12. 78   26. 92  
price/book:  3. 97   3. 06   -1. 74  
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  17. 09 % --- ---
1-yr mean volatility:  0. 13 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 40   2. 40   4. 10  
forward EPS:  -0. 75   3. 97   7. 13  
P/E:  -4. 58   13. 63   22. 72  
forward P/E:  -8. 52   -15. 95   13. 99  
PE/G:  0. 34   -1. 65   -1. 32  
growth:  -13. 48 % 127. 12 % 29. 61 %
earnings high:  -0. 34   1. 00   1. 66  
earnings avg:  -0. 37   0. 77   1. 53  
earnings low:  -0. 38   0. 50   1. 39  
revenue high:  -0. 00   2. 68 B 10. 78 B
revenue avg:  -0. 00   2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -42. 96 % -2. 75 % 4. 55 %
return on equity:  -77. 52 % -18. 45 % 5. 46 %

beta (1yr vs S&P500):  0. 67   1. 25   0. 93  
sharpe (1yr):  0. 59   0. 37   0. 70  

held % insiders:  16. 08 % 6. 39 % 3. 38 %
held % institutions:  40. 23 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : NTEC
.    + 1.132 =         1.132 :: INITIAL WEIGHT
.   + 46.496 =        47.628 :: spline projection addition
.    x 1.431 =        68.176 :: industry recommendation factor
.    x 0.996 =        67.883 :: return on assets factor
.    x 0.992 =        67.357 :: return on equity factor
.    x 2.988 =       201.283 :: current ratio factor
.    x 1.104 =       222.235 :: quick ratio factor
.     x 1.17 =       260.024 :: short ratio factor
.     x 2.04 =       530.363 :: price-to-book factor
.    x 1.046 =       554.653 :: 5-day avg > 200-day avg
.    x 1.226 =       680.055 :: 50-day avg > 200-day avg
.    x 2.095 =       1424.87 :: P/E weight
.     x 1.31 =      1866.396 :: PE/G factor
.    x 1.748 =      3262.355 :: beta factor
.    x 0.593 =      1935.159 :: sharpe factor
.    x 1.812 =      3507.022 :: target low factor
.    x 1.364 =      4782.753 :: target mean factor
.    x 1.129 =      5399.044 :: target high factor
.     x 1.31 =      7072.142 :: industry 2-weeks return factor
.    x 0.929 =      6568.893 :: "drift" penalty 1 days ago
.    x 0.931 =      6116.128 :: "drift" penalty 4 days ago
.    x 0.955 =      5843.801 :: overall "drift" factor
.    x 0.829 =      4845.114 :: largest single-day jump factor
.    x 0.093 =       449.037 :: low price factor
.      x 1.0 =       448.965 :: factor hist industry gain for week 16
.   cubeRoot =         7.657 :: reduced to standardize
.   - 19.785 =         0.068 :: add/subtract for performance
.                      0.068 :: FINAL WEIGHT for NASDAQ:NTEC


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org